Vestiage Closes Private Financings
Vestiage, Inc., a science-based anti aging lifestyle company offering the latest scientifically advanced facial care and supplement solutions to prestige men and women, announced today that it has closed its private financings with several investors. Vestiage will utilize the funds to execute on its several initiatives.
Newport Beach, California (PRWEB) October 02, 2013
Vestiage, Inc. (symbol "VEST"), an anti-aging company located in Newport Beach, California, announced that it has completed a convertible debt offering and an offering of restricted common stock. The financing was completed by the Company without the use of a broker. The majority of the funding came from notable wealthy Boston and East Coast-based families.
"We have made it clear to our shareholders from the beginning that our initiatives will include growing the business both organically and through acquisitions," said Scott Kimball, CEO of Vestiage. "Our existing brands are Reluma, RegiMEN™, and Monterey Bay Nutraceuticals. The Reluma Territory Program launched a few months ago and we are early in the process of buildng out a distribution network for this brand. REgiMEN™ is already sold at GNC, Complete Nutrition and Smoothie King stores and we intend to utilize some of this capital to expand the store counts with those existing customers and add new customers. Monterey Bay Nutraceuticals, a supplement brand created by Vestiage in partnership with Robinson Pharma and key ingredient supplier Nutragenesis, is going into production in October and will be available for purchase at retail stores and online in late Q4. These brands are projected to provide our organic growth. The Vestiage Acquisition Initiative is progressing well as we recently announced the completion of the acquisition of RegiMEN, the premier complete anti-aging supplement system for men. This acquisition fits our strategy to grow Vestiage through acquisition of very select assets that fit a number of Vestiage criteria. We can now state that we are positioned to grow our company with multiple brands."
Monterey Bay Nutraceuticals is an anti-aging oral supplement brand with three products. They are named "Calm and Collected", "Trim and Energized", and "Super Soft Skin". They are designed to be used each morning by women over 40 as a powerful anti-aging combination for skin suppleness, elasticity and moisture from the inside out, mood management, energy, and appetite suppression and weight management as part of an overall weight loss regimen.
"Monterey Bay Nutraceutical products are clean, simple, elegantly formulated with incrredible ingredients, said Garrett heiser, COO of Vestiage. "They are easy on digestion and are packed with ingredients you've heard about from Dr. Oz as well as other patented botanical and marine-based ingredients. We believe once you take these for 30 days, you'll keep on taking them as part of your daily anti-aging regimen."
Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce highly potent, elegantly formulated, effective products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through RegiMEN™ (http://www.BuyREgiMEN.com) and Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on human stem cells, and the best ingredients from the earth and the oceans. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across brands. To learn more, visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb10847417.htm